Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-15T00:09:47.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T21:40:13.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The website has added a 'Show less' feature while removing extensive details about participant groups, interventions, and various data fields available for download.
    Difference
    3%
    Check dated 2024-11-23T05:48:24.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, adding new features for downloading study data in various formats and displaying detailed participant and study information, while removing the option to show less content.
    Difference
    3%
    Check dated 2024-11-08T19:02:28.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.0 to v2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T11:27:36.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.
    Difference
    0.1%
    Check dated 2024-10-25T00:51:28.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.